Methods , systems and devices for noninvasive pulmonary delivery

Details for Australian Patent Application No. 2005247410 (hide)

Owner Discovery Laboratories, Inc.

Inventors Johnson, Mark; Brown, David; Thomas, Matthew; Niven, Ralph; Rairkar, Maithili; Watanabe, Wiwik

Agent Pizzeys

Pub. Number AU-A-2005247410

PCT Pub. Number WO2005/115520

Priority 60/673,155 20.04.05 US; 60/573,570 20.05.04 US; 60/639,503 27.12.04 US

Filing date 17 May 2005

Wipo publication date 8 December 2005

International Classifications

A61M 16/08 (2006.01) Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration - Bellows

A61M 11/00 (2006.01) Sprayers

A61M 16/00 (2006.01) Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration

A61M 16/10 (2006.01) Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration - Preparation of respiratory gases or vapours

Event Publications

14 December 2006 PCT application entered the National Phase

  PCT publication WO2005/115520 Priority application(s): WO2005/115520

4 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005247419-Compositions containing a nopal cactus isolate and method for making same

2005247409-Treating seizures using ICE inhibitors